WILLIAM ALSUP, District Judge.
Plaintiff Norma Scott and defendants Bayer Corporation, Bayer HealthCare LLC, Bayer Essure Inc., and Bayer HealthCare Pharmaceuticals Inc. (collectively, "Bayer") hereby stipulate and agree as follows:
1. Plaintiff filed her complaint on May 16, 2016, in the Superior Court for the State of California, County of Alameda, asserting claims involving the Essure® Permanent Birth Control System (the "Essure Device").
2. Bayer removed this action to federal court on June 16, 2016. [Dkt. No. 1].
3. Bayer filed its Motion to Dismiss on June 23, 2016. [Dkt. No. 14]. Pursuant to the Local Rules, Plaintiff's opposition is due on July 7, and Bayer's reply is due on July 14. [Id.].
4. Thereafter, the matter was reassigned to the Honorable William. H. Alsup. [Dkt. No. 22]. Pursuant to the Related Case Order entered on June 30, 2016, the Court instructed Bayer, as the moving party on the Motion to Dismiss, to re-notice its Motion to Dismiss. [Id.].
5. This case is related to Aigner, et al. v. Bayer Corporation, et al., No. 3:16-cv-03437-WHA, and Bayer has filed a similar Motion to Dismiss in that case.
6. The parties have met and conferred on a briefing schedule that will permit a coordinated hearing on the motions to dismiss in Scott and Aigner. In addition, Plaintiffs in this case and in Aigner have indicated that they will be filing Motion to Remands the actions to the Superior Court for the State of California, s.
7. In the interests of efficiency and to permit coordination of briefing and hearing of the issues among the related cases, the parties agree to and request the Court to order the following briefing schedule for Bayer's Motion to Dismiss and Plaintiff's anticipated Motion to Remand, which is the first time the parties have requested this type of relief and which will not otherwise affect the schedule in this case:
IT IS SO STIPULATED.
PURSUANT TO THE PARTIES STIPULATION, and for good cause shown, IT IS ORDERED THAT: